A detailed history of Gamma Investing LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Gamma Investing LLC holds 94 shares of HAE stock, worth $7,291. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94
Previous 137 31.39%
Holding current value
$7,291
Previous $11.3 Million 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$72.45 - $91.58 $3,115 - $3,937
-43 Reduced 31.39%
94 $7.56 Million
Q2 2024

Jul 02, 2024

BUY
$81.24 - $97.37 $8,855 - $10,613
109 Added 389.29%
137 $11.3 Million
Q1 2024

Apr 05, 2024

SELL
$71.24 - $85.35 $2,208 - $2,645
-31 Reduced 52.54%
28 $2.39 Million
Q4 2023

Feb 01, 2024

BUY
$80.59 - $92.61 $4,754 - $5,463
59 New
59 $4.51 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.98B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.